Loading...
Loading...
All product recalls associated with Aurobindo Pharma USA Inc.
Total Recalls
1000
Past Year
1000
Class I (Serious)
127
Most Recent
Jan 2026
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Lack of Sterility Assurance
Contains undeclared drugs Acetaminophen and Dexamethasone Phosphate, and the undeclared sweetener Aspartame